In a step toward personalized medicine, researchers are reporting that the use of genetic testing to guide selection of blood thinner medication led to a 34% decrease in the number of patients who had serious adverse events following balloon angioplasty, a common treatment for heart disease.
Get in Touch
Contact us with questions or to order resources on The Heart Truth. You can also stay up to date on the latest news, events, and information from the NHLBI with our email alerts.
For access to free Telecommunications Relay Services (TRS), dial 7-1-1 on your telephone.